Second-line treatment of hepatocellular carcinoma: from theory to practical issues

Por V. V. Breder, K. K. Laktionov
Publicado em 2019-12-01

Ceritinib in the treatment of ALK-positive patients with nonsmall-cell lung cancer

Por K. K. Laktionov, E. V. Reutova
Publicado em 2019-06-01

Immunotherapy for hepatocellular cancer: beginning and future perspectives

Por M. A. Kazantseva, V. V. Breder, K. K. Laktionov
Publicado em 2019-06-01

PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS

Por V. V. Breder, K. K. Laktionov, M. I. Davydov
Publicado em 2017-11-01

Efficacy of lorlatinib in the treatment of ALK-positive non-small cell lung cancer patients with progression on crizotinib: personal experience

Por K. K. Laktionov, E. V. Reutova, S. Yu. Kruteleva, E. Yu. Antonova
Publicado em 2021-12-01

Rational approach to the treatment of EGFR-positive lung cancer

Por E. V. Reutova, K. K. Laktionov, D. I. Yudin, M. S. Ardzinba
Publicado em 2019-12-01

TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT

Por K. K. LAKTIONOV, E. V. REUTOVA, M. S. ARDZINBA, N. A. MESCHERYAKOVA
Publicado em 2017-06-01

Рembrolizumab as second line therapy for hepatocellular patient

Por I. A. Dzhanyan, V. V. Breder, O. I. Borisova, K. K. Laktionov
Publicado em 2021-12-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

Por V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Publicado em 2020-07-01

Immunotherapy for small-cell lung cancer

Por A. Ye. Kuzminov, K. K. Laktionov, A. A. Yegorova, V. V. Breder, T. D. Barbolina
Publicado em 2019-06-01

Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer

Por K. K. Laktionov, A. M. Kazakov, K. A. Sarantseva, D. S. Scherbo, A. P. Koval
Publicado em 2022-03-01

Clinical case of use of osimertinib in a patient with disseminated EGFR-mutated non-small cell lung cancer in the first-line therapy

Por K. A. Sarantseva, K. K. Laktionov, E. V. Reutova, D. I. Yudin, V. V. Breder
Publicado em 2020-12-01

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment

Por A. E. Kuzminov, T. N. Borisova, V. V. Breder, E. V. Reutova, T. D. Barbolina, K. K. Laktionov
Publicado em 2020-07-01

The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data...

Por A E Kuzminov, V A Gorbunova, E V Poddubskaya, S G Bagrova, M P Baranova, K K Laktionov
Publicado em 2018-09-01

Fibrolamellar liver cancer: the modern concept

Por E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov
Publicado em 2020-12-01

Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

Por K. K. Laktionov, K. A. Sarantseva, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov
Publicado em 2019-12-01

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started

Por V. V. Breder, M. U. Pitkevich, E. R. Virshke, L. A. Kostyakova, I. A. Dzhanyan, K. K. Laktionov
Publicado em 2018-07-01

A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma

Por K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, K. P. Laktionov, V. V. Breder, E. V. Reutova
Publicado em 2018-07-01

Abscopal effect in a patient with metastatic NSCLC following a course of radiation therapy to the brain

Por E. S. Denisova, K. K. Laktionov, T. N. Borisova, Merab. S. Ardzinba, A. A. Fedorova, D. I. Yudin, S. S. Magamedova, Milada A. Ardzinba
Publicado em 2020-12-01

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

Por E. S. Denisova, M. S. Ardzinba, K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, G. V. Shcherbakova, N. V. Marinichenko
Publicado em 2020-07-01